• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CODMAN AND SHURTLEFF, INC STENT - VASCULAR RECONSTRUCTION; INTRACRANIAL NEUROVASCULAR STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CODMAN AND SHURTLEFF, INC STENT - VASCULAR RECONSTRUCTION; INTRACRANIAL NEUROVASCULAR STENT Back to Search Results
Catalog Number UNKENTERPRISE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Thromboembolism (2654)
Event Date 12/31/2014
Event Type  Injury  
Manufacturer Narrative
Manufacturer¿s ref.No: (b)(4).No device was received for analysis at the time of submission of the initial 3500a.Since the product was not returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because the lot number was provided by the customer.Cerenovus manufacturer's report number: 1226348-2021-00058 is related to the same incident.
 
Event Description
This complaint is from a literature source.The following complications were reported in this publication: it was reported that 1 patient underwent endovascular treatment for basilar artery trunk aneurysm and suffered thrombosis which spontaneously resolved.Model and catalog number are not available, but the suspected device is enterprise stent other cnv devices that were also used in this study: envoy, prowler 14 mc, non-cnv devices that were also used in this study: excelsior sl-10 microcatheter, neuroform stent, solitaire ab stent, hyperglide, perclose publication details: title: saccular or dissecting aneurysms involving the basilar trunk: endovascular treatment and clinical outcome objective: : basilar artery trunk aneurysms (btas) are a rare pathology and difficult to treat.We present our experience regarding angiographic results and clinical outcomes for 16 btas treated by reconstructive endovascular treatment (evt) using stent or balloon.Methods: between january 2003 and december 2014, 15 patients (mean age, 58.6 years; 11 males) with 16 btas were enrolled.Clinical manifestation, outcomes and procedural complications were evaluated retrospectively, and follow-up angiography was performed 12 and 24 months after procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STENT - VASCULAR RECONSTRUCTION
Type of Device
INTRACRANIAL NEUROVASCULAR STENT
Manufacturer (Section D)
CODMAN AND SHURTLEFF, INC
325 paramount dr
raynham MA 02767
MDR Report Key12502828
MDR Text Key282033333
Report Number1226348-2021-00057
Device Sequence Number1
Product Code NJE
Combination Product (y/n)N
PMA/PMN Number
H60001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature
Type of Report Initial
Report Date 09/06/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Catalogue NumberUNKENTERPRISE
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 09/06/2021
Initial Date FDA Received09/20/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ENVOY; EXCELSIOR SL-10 MICROCATHETE; HYPERGLIDE; NEUROFORM STENT; PERCLOSE; PROWLER 14 MC; SOLITAIRE AB STENT
Patient Outcome(s) Other;
Patient Age59 YR
-
-